• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Glycorex Transplantation

1.77 SEK

+5.99 %

Less than 1K followers

GTAB B

NGM Main Regulated

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+5.99 %
+46.28 %
+32.09 %
+11.32 %
+16.45 %
-22.71 %
-40.00 %
-82.41 %
-82.57 %

Glycorex Transplantation is active in biotechnology. The company conducts research, development and marketing in the field of organ transplantation. The company's main product enables transplants regardless of the blood type of the donor or recipient. Transplantation using the company's product is carried out on a global level. Glycorex Transplantation was founded in 1996 and has its headquarters in Lund.

Read more
Market cap
139.57M SEK
Turnover
7.13K SEK
Revenue
38.84M
EBIT %
-18.86 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
28/8
2026

Interim report Q2'26

27/11
2026

Interim report Q3'26

All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Press release2026-06-16 10:19

Glycorex Transplantation (GTAB B): Ny ordförande - rättelse

Glycorex Transplantation
Regulatory press release2026-06-15 07:45

Glycorex Transplantation (GTAB B): Ny ordförande

Glycorex Transplantation
Regulatory press release2026-06-04 21:23

Glycorex Transplantation (GTAB B): Årsstämman 4 juni 2026

Glycorex Transplantation

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release2026-06-03 11:29

Glycorex Transplantation (GTAB B): Ny ledamot

Glycorex Transplantation
Regulatory press release2026-05-22 08:00

Glycorex Transplantation AB (GTAB B): Delårsrapport januari - mars 2026

Glycorex Transplantation
Regulatory press release2026-05-08 16:14

Glycorex Transplantation AB utser Carl-Magnus Högerkorp till ny VD

Glycorex Transplantation
Regulatory press release2026-05-05 15:30

Glycorex Transplantation (GTAB B): Kallelse till årsstämma 4 juni 2026

Glycorex Transplantation
Regulatory press release2026-04-30 10:36

Glycorex Transplantation AB (GTAB B) offentliggör årsredovisning för 2025

Glycorex Transplantation
Press release2026-03-09 08:59

Glycorex Transplantation: Rekrytering ny VD

Glycorex Transplantation
Regulatory press release2026-02-25 08:00

Glycorex Transplantation AB (GTAB B): Bokslutskommuniké 2025

Glycorex Transplantation
Press release2026-02-06 13:47

Glycorex Transplantation: JHLT-uppmärksammad studie om ABO-inkompatibel pediatrisk transplantation

Glycorex Transplantation
Press release2026-02-06 13:47

Glycorex Transplantation: JHLT-recognised ABO-incompatible paediatric transplant study

Glycorex Transplantation
Regulatory press release2025-11-28 08:00

Glycorex Transplantation AB (GTAB B): Delårsrapport januari - september 2025

Glycorex Transplantation
Press release2025-11-18 17:51

Glycorex Transplantation AB (GTAB B): Vunnen upphandling

Glycorex Transplantation
Press release2025-09-25 15:22

Glycorex Transplantation AB (GTAB B): Levererar Glycosorb® ABO (4 mL) till Frankrike

Glycorex Transplantation
Regulatory press release2025-08-29 08:00

Glycorex Transplantation AB (GTAB B): Delårsrapport januari - juni 2025

Glycorex Transplantation
Press release2025-08-13 12:50

Glycorex Transplantation (GTAB B): First ABO-incompatible organ transplantion in Morocco with Glycosorb® ABO

Glycorex Transplantation
Press release2025-08-13 12:50

Glycorex Transplantation (GTAB B): Första blodgruppsinkompatibla organtransplantationen i Marocko med Glycosorb® ABO

Glycorex Transplantation
Press release2025-05-26 19:43

Glycorex Transplantation (GTAB B): Årsstämman 26 maj 2025

Glycorex Transplantation
Regulatory press release2025-05-23 08:00

Glycorex Transplantation AB (GTAB B): Delårsrapport januari - mars 2025

Glycorex Transplantation